Managers / Q2 2022 · view latest →
McBroom & Associates, LLC
CIK 0001908893 · 1635 VILLAGE CENTER CIRCLE, SUITE 140, LAS VEGAS, NV, 89134 · (702) 267-6649
Summary
Mcbroom & Associates, LLC reported $92M in U.S.-listed holdings across 29 positions for Q2 2022.
Its largest position, COST, represents 6.1% of the portfolio.
Compared with Q1 2022, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 76.9% · $71M
- ETP · 18.1% · $17M
- Other · 5.0% · $5M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2022 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SWCHEURSWITCH INC | NEW | +7.3K | 7.3K | +$246,000 | $246,000 |
| AMZNAMAZON COM INC | ADDED | +29.6K | 31.2K | −$2M | $3M |
| NUENUCOR CORP | ADDED | +12.3K | 23.3K | +$800,000 | $2M |
| DBCINVESCO DB COMMDY INDX TRCK | ADDED | +57.6K | 116.5K | +$2M | $3M |
| SCHWAB STRATEGIC TR | TRIMMED | −6.7K | 6.8K | −$359,000 | $326,000 |
| BABOEING CO | TRIMMED | −3.0K | 15.9K | −$1M | $2M |
| SCHWAB STRATEGIC TR | TRIMMED | −13.5K | 79.1K | −$696,000 | $4M |
| COSTCOSTCO WHSL CORP NEW | TRIMMED | −931 | 11.8K | −$2M | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $180M | 36 | Apr 23, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $206M | 38 | Jan 20, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $210M | 37 | Oct 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $175M | 37 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $175M | 37 | Apr 17, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $177M | 35 | Jan 29, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $163M | 34 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $160M | 33 | Aug 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $152M | 33 | Apr 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $137M | 33 | Jan 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $126M | 36 | Oct 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $127M | 37 | Jul 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $112M | 36 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $92M | 35 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $89M | 35 | Oct 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $92M | 29 | Jul 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $113M | 28 | May 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $133M | 30 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.